What the name refers to
A growth-hormone-releasing factor analogue authorised for reduction of excess abdominal fat in certain adults with HIV-associated lipodystrophy.
Evidence and regulatory context
At least one regulated medicine or indication exists for this active ingredient. Authorisation is tied to a particular formulation, manufacturer, indication and jurisdiction; it does not validate unrelated products using the same name.
Reading product records
The record should distinguish a regulated medicine from a research-labelled analogue and state the exact molecule. For injectables, identity and quantity do not replace sterility, endotoxin, storage and batch-traceability information.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.